269 related articles for article (PubMed ID: 211931)
1. Acetylcholine release in diaphragm of rats with chronic experimental autoimmune myasthenia gravis.
Kelly JJ; Lambert EH; Lennon VA
Ann Neurol; 1978 Jul; 4(1):67-72. PubMed ID: 211931
[TBL] [Abstract][Full Text] [Related]
2. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
[TBL] [Abstract][Full Text] [Related]
3. Facilitatory effects of 4-aminopyridine on neuromuscular transmission in disease states.
Kim YI; Goldner MM; Sanders DB
Muscle Nerve; 1980; 3(2):112-9. PubMed ID: 6245355
[TBL] [Abstract][Full Text] [Related]
4. Presynaptic function modified by acetylcholine-receptor interaction in experimental autoimmune myasthenia gravis.
Takamori M; Sakato S; Okumura S
J Neurol Sci; 1984; 66(2-3):245-53. PubMed ID: 6099402
[TBL] [Abstract][Full Text] [Related]
5. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
[TBL] [Abstract][Full Text] [Related]
6. End-plate potentials in experimental autoimmune myasthenia gravis in rats.
Lambert EH; Lindstrom JM; Lennon VA
Ann N Y Acad Sci; 1976; 274():300-18. PubMed ID: 1066990
[TBL] [Abstract][Full Text] [Related]
7. Congenital canine myasthenia gravis: I. Deficient junctional acetylcholine receptors.
Oda K; Lambert EH; Lennon VA; Palmer AC
Muscle Nerve; 1984; 7(9):705-16. PubMed ID: 6543919
[TBL] [Abstract][Full Text] [Related]
8. Chronic experimental autoimmune myasthenia gravis induced by monoclonal antibody to acetylcholine receptor: biochemical and electrophysiologic criteria.
Gomez CM; Richman DP
J Immunol; 1987 Jul; 139(1):73-6. PubMed ID: 3035025
[TBL] [Abstract][Full Text] [Related]
9. Neuromuscular Transmission in experimental autoimmune myasthenia gravis (EAMG). Quantitative ionophoresis and current fluctuation analysis at normal and myasthenic rat end-plates.
Hohlfeld R; Sterz R; Kalies I; Peper K; Wekerle H
Pflugers Arch; 1981 May; 390(2):156-60. PubMed ID: 6264388
[TBL] [Abstract][Full Text] [Related]
10. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
Andreis I; Lovnićki TJ; Beara N; Taradi M
Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
[TBL] [Abstract][Full Text] [Related]
11. The neuromuscular junction: recent developments.
Bowman WC
Eur J Anaesthesiol; 1985 Mar; 2(1):59-93. PubMed ID: 2410263
[No Abstract] [Full Text] [Related]
12. Presynaptic and postsynaptic actions of procainamide on neuromuscular transmission.
Lee DC; Kim YI; Liu HH; Johns TR
Muscle Nerve; 1983; 6(6):442-7. PubMed ID: 6312309
[TBL] [Abstract][Full Text] [Related]
13. A possible role for the acetylcholine transport system in non-quantal release of acetylcholine at the rodent myoneural junction.
Edwards C; Dolezal V; Tucek S; Zemkova H; Vyskocil F
P R Health Sci J; 1988 Aug; 7(2):71-4. PubMed ID: 2847217
[TBL] [Abstract][Full Text] [Related]
14. Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations.
Engel AG; Tsujihata M; Lambert EH; Lindstrom JM; Lennon VA
J Neuropathol Exp Neurol; 1976; 35(5):569-87. PubMed ID: 956872
[TBL] [Abstract][Full Text] [Related]
15. Structure-function correlations in myasthenia gravis and a new myasthenic syndrome.
Engel AG; Lambert EH
Electroencephalogr Clin Neurophysiol Suppl; 1978; (34):469-77. PubMed ID: 220007
[TBL] [Abstract][Full Text] [Related]
16. Myasthenia gravis. Current concepts.
Gutmann L; Chou SM
Arch Pathol Lab Med; 1976 Aug; 100(8):401-4. PubMed ID: 947303
[TBL] [Abstract][Full Text] [Related]
17. Factors contributing to failure of neuromuscular transmission in myasthenia gravis and the special case of the extraocular muscles.
Serra A; Ruff R; Kaminski H; Leigh RJ
Ann N Y Acad Sci; 2011 Sep; 1233():26-33. PubMed ID: 21950972
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis.
Losen M; Stassen MH; Martínez-Martínez P; Machiels BM; Duimel H; Frederik P; Veldman H; Wokke JH; Spaans F; Vincent A; De Baets MH
Brain; 2005 Oct; 128(Pt 10):2327-37. PubMed ID: 16150851
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural aspects of acetylcholine receptor turnover at the normal end-plate and in autoimmune myasthenia gravis.
Fumagalli G; Engel AG; Lindstrom J
J Neuropathol Exp Neurol; 1982 Nov; 41(6):567-79. PubMed ID: 6982313
[TBL] [Abstract][Full Text] [Related]
20. Passive transfer of seronegative myasthenia gravis to mice.
Burges J; Vincent A; Molenaar PC; Newsom-Davis J; Peers C; Wray D
Muscle Nerve; 1994 Dec; 17(12):1393-400. PubMed ID: 7969240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]